Tests enhanced external counterpulsation with cardiac rehabilitation in atrial fibrillation
Tests a combined therapy with rehabilitation exercise in adults with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Effects of Enhanced External Counterpulsation Combined With Cardiac Rehabilitation in Patients With Atrial Fibrillation
Key facts
- Where
- Lanzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT07058987, who can take part
Where in China
- Lanzhou University Second HospitalLanzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Lanzhou University Second Hospital
- Trial code
- NCT07058987
- Record updated
- 14 July 2025
- Original description
This is a prospective randomized controlled trial designed to evaluate the effectiveness of enhanced external counterpulsation (EECP) combined with cardiac rehabilitation in patients with atrial fibrillation. The study aims to assess whether this combined intervention can improve cardiac function and exercise capacity compared to standard care alone. Eligible participants will be randomly assigned to receive either the EECP plus cardiac rehabilitation program or routine treatment. Primary outcomes include changes in left ventricular ejection fraction (LVEF) and six-minute walking distance (6MWD). The study will be conducted at Lanzhou University Second Hospital.Read full original descriptionShow less
A Prospective Randomized Controlled Study on the Effects of Enhanced External Counterpulsation Combined With Cardiac Rehabilitation on Cardiac Function and Exercise Capacity in Patients With Atrial Fibrillation
This is a prospective randomized controlled trial designed to evaluate the effectiveness of enhanced external counterpulsation (EECP) combined with cardiac rehabilitation in patients with atrial fibrillation. The study aims to assess whether this combined intervention can improve cardiac function and exercise capacity compared to standard care alone. Eligible participants will be randomly assigned to receive either the EECP plus cardiac rehabilitation program or routine treatment. Primary outcomes include changes in left ventricular ejection fraction (LVEF) and six-minute walking distance (6MWD). The study will be conducted at Lanzhou University Second Hospital.
Inclusion: Age between 40 and 80 years; Diagnosed with persistent or paroxysmal atrial fibrillation, confirmed by ECG or Holter; Stable medical condition and able to participate in cardiac rehabilitation and EECP therapy; Provided written informed consent.
Exclusion: Recent acute myocardial infarction, unstable angina, or decompensated heart failure within the past 4 weeks; Severe peripheral vascular disease or deep vein thrombosis; Severe pulmonary disease or active infection; History of bleeding disorders or contraindications to EECP; Cognitive impairment or psychiatric condition affecting study participation; Severe valvular heart disease or left ventricular ejection fraction <30%; Participation in another clinical trial within the past 3 months.